MARKER THERAPEUTICS, INC. Income (Loss) from Continuing Operations, Per Basic Share
MARKER THERAPEUTICS, INC. (MRKR) reported Income (Loss) from Continuing Operations, Per Basic Share of -$1.19 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2025-03-31
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was -$0.26.
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-06-30 was -$0.25.
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-03-31 was -$0.27.
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2023-09-30 was -$0.34.
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for fiscal 2024 was -$1.19.
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for fiscal 2023 was -$1.59.
- MARKER THERAPEUTICS, INC. income (loss) from continuing operations, per basic share for fiscal 2022 was -$2.37.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$1.19 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$0.26 10-Q · filed 2024-11-14 | -$0.77 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | -$0.25 10-Q · filed 2024-08-14 | -$0.51 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | -$0.27 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | -$1.59 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$0.34 10-Q · filed 2024-11-14 | -$1.29 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$0.47 10-Q · filed 2024-08-14 | -$0.95 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$0.48 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$2.37 10-K · filed 2024-03-26 | |||
| 2022-09-30 | -$0.69 10-Q · filed 2023-11-09 | -$2.01 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.63 10-Q · filed 2023-08-14 | -$1.32 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |